Christopher Moxham Fulcrum Therapeutics, Inc. (FULC) insider trading activity

FULC Quotes by TradingView

Christopher Moxham is Chief Scientific Officer of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 0 shares of FULC, which is worth approximately $0. The most recent transaction as insider was on Aug 10, 2021, when has been sold 20,714 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $352,138. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Christopher Moxham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 10 2021
SELL
Open market or private sale
$352,138 $17.0 p/Share
20,714 Reduced 100.0%
0 Common Stock
Aug 10 2021
SELL
Open market or private sale
$559,278 $18.0 p/Share
31,071 Reduced 100.0%
0 Common Stockm
Aug 10 2021
BUY
Exercise of conversion of derivative security
$405,994 $7.84 p/Share
51,785 Added 62.5%
31,071 Common Stock
CM

Christopher Moxham

Chief Scientific Officer
Cambridge, MA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FULC